Suppr超能文献

2008-2009 年住院成年患者中奥司他韦耐药(H275Y)和同时存在的奥司他韦敏感季节性甲型 H1N1 流感病毒感染的比较。

Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008-2009.

机构信息

Department of Microbiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

出版信息

Influenza Other Respir Viruses. 2013 May;7(3):235-9. doi: 10.1111/j.1750-2659.2012.00387.x. Epub 2012 Jun 14.

Abstract

In an observational cohort study, we found that adults hospitalized for oseltamivir-resistant (H275Y) seasonal H1N1 influenza (n = 46) were older than those infected with oseltamivir-susceptible strains (n = 31) [74(IQR 59-83) versus 64(IQR 48-76) years; P = 0·045], and most had major comorbidities (78% versus 65%). Disease severity and clinical outcomes were comparable between the two groups: radiographic pneumonia 40-42%, supplemental oxygen use 47-48%, critical illness 11-13%, median duration of hospitalization 5-6 days, death rate 6-9%. Failure to receive effective antiviral therapy was associated with progression to critical illness (23% versus 0%, P = 0·016) and death (20% versus 0%, P = 0·033) in hospitalized patients with seasonal H1N1 influenza.

摘要

在一项观察性队列研究中,我们发现因耐奥司他韦(H275Y)季节性 H1N1 流感住院的成年人(n = 46)比感染奥司他韦敏感株的成年人(n = 31)年龄更大[74(IQR 59-83) 岁比 64(IQR 48-76) 岁;P = 0·045],且大多数人患有主要合并症(78%比 65%)。两组的疾病严重程度和临床结局相当:影像学肺炎 40-42%,补充氧气使用 47-48%,重症病例 11-13%,住院中位时间 5-6 天,死亡率 6-9%。接受有效抗病毒治疗失败与季节性 H1N1 流感住院患者进展为重症病例(23%比 0%,P = 0·016)和死亡(20%比 0%,P = 0·033)相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf9/5779845/2166f95e9387/IRV-7-235-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验